REQUEST A DEMO
Total
USD $0.00
Search more companies

Teleflex Medical Asia Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Management Consulting Services
Full name: Teleflex Medical Asia Pte. Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Teleflex Medical Asia Pte. Ltd. is a company based in Singapore, with its head office in Singapore. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on September 18, 1991. The company’s latest financial report indicates a net sales revenue drop of 8.26% in 2024. Its total assets decreased by 9.81% over the same period. The net profit margin of Teleflex Medical Asia Pte. Ltd. increased by 0.28% in 2024.

Headquarters
83 Clemenceau Avenue, #05-05-08 Ue Square, Singapore
Singapore; Singapore; Postal Code: 239920

Contact Details: Purchase the Teleflex Medical Asia Pte. Ltd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Teleflex Medical Asia Pte. Ltd. report to view the information.
Incorporation Date:
September 18, 1991
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Teleflex Medical Asia Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-8.26%
Total Operating Revenue
-8.26%
Net Profit/Loss for the Period
-4.75%
Total Assets
-9.81%
Total Equity
25.93%
Net Profit Margin
0.28%
Return on Equity (ROE)
-6.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?